With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Epigenetic Characterization of the Neuroblastoma Driver Genes ARID1A and ARID1B||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2013||Pennsylvania|
|Dissecting the Mechanism of Overgrowth and Tumorigenesis in Beckwith-Wiedemann Syndrome||University of Pennsylvania / Jennifer Kalish, MD, PhD||Young Investigator Grants||2013||Pennsylvania|
|Defining the Mechanism by which LIN28B acts as an Oncogene in Neuroblastoma||Children's Hospital of Philadelphia / Robert Schnepp, MD, PhD||Young Investigator Grants||2013||Pennsylvania|
|DICER1, MicroRNAs and Pediatric Cancer: An Emerging Story||Research Institute of the McGill University Health Centre / William Foulkes, MD, PhD||Innovation Grants||2013||Quebec|
|Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy||Palmetto Health / Janice Withycombe, PhD||Nurse Researcher Grants||2013||South Carolina|
|Inflammatory Signaling in the Tumor Microenvironment||St. Jude Children's Research Hospital / Peter J. Murray, PhD||Springboard Grants||2013||Tennessee|
|Genetic Profiling and Experimental Modeling of High-risk Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Kathryn Roberts, PhD||Young Investigator Grants||2013||Tennessee|
|Novel Targeted Therapies for Rhabdomyosarcoma||St. Jude Children's Research Hospital / Michael Dyer, PhD||Innovation Grants||2013||Tennessee|
|B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers||University of Texas Southwestern Medical Center / James Amatruda, MD, PhD||Reach Grants||2013||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|